Ticker
ACXPCompany Name
ACURX PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Issuance (Repayment) of Debt Securities | Net Cash Flow - Dividends & Other Cash Distributions | Shareholder Yield |
---|---|---|---|---|---|
6/30/2025 | $ 7.1M | $ 5.39M | $ 0 | $ 0 | -75.85% |
3/31/2025 | $ 9.28M | $ 5.09M | $ 0 | $ 0 | -54.88% |
12/31/2024 | $ 10.43M | $ 6.41M | $ 0 | $ 0 | -61.43% |
9/30/2024 | $ 31.25M | $ 8.61M | $ 0 | $ 0 | -27.56% |
6/30/2024 | $ 30.87M | $ 7.02M | $ 0 | $ 0 | -22.74% |
3/31/2024 | $ 33.11M | $ 6.7M | $ 0 | $ 0 | -20.23% |
12/31/2023 | $ 42.86M | $ 5.94M | $ 0 | $ 0 | -13.87% |
9/30/2023 | $ 48.19M | $ -1 | $ 0 | $ 0 | 0% |
6/30/2023 | $ 23.71M | $ 3.7M | $ 0 | $ 0 | -15.59% |
3/31/2023 | $ 35.37M | $ 3.7M | $ 0 | $ 0 | -10.45% |
(-1 * CF - Equity -1 * CF - Dividends -1 * CF - Debt) / Market Cap
(=) Shareholder Yield
Shareholder Yield for ACURX PHARMACEUTICALS INC is calculated as follows: (-1 * CF - Equity [ $ 3.98M ] -1 * CF - Dividends [ $ 0 ] -1 * CF - Debt [ $ 66.5K ]) / Market Cap [ $ 0 ]
(=) Shareholder Yield [ 0% ]
Minimum
Jun 30, 2025
Maximum
Sep 30, 2023
Average
Median
filtered constituents | 3.48K |
---|---|
min | -33.43% |
max | 34.45% |
average | 0.58% |
median | 1.07% |
std | 11.13% |